Lee Shapiro

Lee Shapiro is the Managing Partner at 7WireVentures, an investment firm he co-founded over a decade ago. He served as CFO of Livongo Health [NASDAQ:LVGO] until November 2020 and was President of Allscripts [NASDAQ:MDRX] from 2001 to 2012. His leadership was key in executing over $4B in mergers, acquisitions, and financings.

Before becoming CFO of Livongo and leading its 2019 IPO, Lee served on the board, chaired the audit committee, and was a member of the compensation committee. During his tenure, Livongo had a successful secondary offering, raised $550M in convertible debt, and entered into a merger agreement valued at $18.5B. The share price of $159 was over six times the IPO price just 12 months earlier.

Lee serves on the board of Clover Health [NASDAQ:CLOV] and has served on the boards of Senior Connect [NASDAQ:SNRH], Medidata Solutions [NASDAQ:MDSO] until its sale in 2019, and Tivity Health [NASDAQ:TVTY] until May 2020. In January 2021, he joined the board of Click Therapeutics and serves on the boards and committees of various 7wireVentures portfolio companies.

For the past 6 years, Lee has been a member of the National Board of Directors of the American Heart Association, where he is chair-elect, after serving as Audit Committee chair and Treasurer. He is a co-founder and board member of The World Innovation Network, serves on the University of Chicago Innovation Fund Advisory Committee, and has been on the Samsung Digital Health Advisory Board and Qualcomm Life Advisory Board. Lee is a frequent speaker at industry conferences and a published contributor to the Forbes Business Council. He has also served as an officer and director of the Gastro-Intestinal Research Foundation (GIRF).

Lee practiced commercial law at Barack, Ferrazzano, Kirschbaum, Perlman and Nagelberg, a prominent Chicago law firm. He holds a JD from The University of Chicago Law School and a BS in Accounting from the University of Illinois.